FDA declines to authorize common antidepressant as COVID treatment
By Leroy Leo and Michael Erman (Reuters) - The U.S. Food and Drug Administration has decided not to authorize the antidepressant fluvoxamine to treat ...
Source: wsau.com
📰 Michael Erman News
Page 53 - Michael Erman News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Erman. Real-time updates on events, politics, business and more.
U.S. says use of Pfizer's COVID-19 antiviral up 315%
By Ahmed Aboulenein WASHINGTON -Rising COVID-19 cases are driving up the use of therapeutics, with Pfizer Inc's oral antiviral treatment Paxlovid seeing a
Source: shorenewsnetwork.com
FDA declines to authorize common antidepressant as COVID treatment
By Leroy Leo and Michael Erman (Reuters) - The U.S. Food and Drug Administration has decided not to authorize the antidepressant fluvoxamine to treat ...
Source: whbl.com
FDA declines to authorize common antidepressant as COVID treatment
By Leroy Leo and Michael Erman (Reuters) - The U.S. Food and Drug Administration has decided not to authorize the antidepressant fluvoxamine to treat ...
Source: wtvbam.com
FDA declines to authorize common antidepressant as COVID treatment
By Leroy Leo and Michael Erman (Reuters) - The U.S. Food and Drug Administration has decided not to authorize the antidepressant fluvoxamine to treat ...
Source: mymixfm.com
FDA declines to authorize common antidepressant as COVID treatment
By Leroy Leo and Michael Erman (Reuters) - The U.S. Food and Drug Administration has decided not to authorize the antidepressant fluvoxamine to treat ...
Source: wtaq.com
Explainer-Some patients reporting COVID rebounds after taking Pfizer pills
By Michael Erman (Reuters) - More than 2.8 million courses of Pfizer Inc's COVID-19 oral antiviral treatment Paxlovid have been made available at phar...
Source: wkzo.com
Some patients reporting COVID rebounds after taking Pfizer pills
More than 2.8 million courses of Pfizer Inc’s COVID-19 oral antiviral treatment Paxlovid have been made available at pharmacies around the United States, with…
Source: financialpost.com
COVID vaccine makers shift focus to boosters
By Michael Erman and Manas Mishra (Reuters) - COVID-19 vaccine makers are shifting gears and planning for a smaller, more competitive booster shot mar...
Source: whbl.com
COVID vaccine makers shift focus to boosters
COVID-19 vaccine makers are shifting gears and planning for a smaller, more competitive booster shot market after delivering as many doses as fast as they could over the last 18 months. Executives at the biggest COVID vaccine makers including Pfizer Inc and Moderna Inc said they believe most people who wanted to get vaccinated against COVID have already done so - more than 5 billion people worldwide. In the coming year, most COVID vaccinations will be booster shots, or first inoculations for c...
Source: aol.com